Literature DB >> 24426167

Physiological and Immunological Regulations in Caenorhabditis elegans Infected with Salmonella enterica serovar Typhi.

Bhagavathi Sundaram Sivamaruthi1, Krishnaswamy Balamurugan1.   

Abstract

Studies pertaining to Salmonella enterica serovar Typhimurium infection by utilizing model systems failed to mimic the essential aspects of immunity induced by Salmonella enterica serovar Typhi, as the determinants of innate immunity are distinct. The present study investigated the physiological and innate immune responses of S. Typhi infected Caenorhabditis elegans and also explored the Ty21a mediated immune enhancement in C. elegans. Ty21a is a known live vaccine for typhoidal infection in human beings. Physiological responses of C. elegans infected with S. Typhi assessed by survival and behavioral assays revealed that S. Typhi caused host mortality by persistent infection. However, Ty21a exposure to C. elegans was not harmful. Ty21a pre-exposed C. elegans, exhibited significant resistance against S. Typhi infection. Elevated accumulation of S. Typhi inside the infected host was observed when compared to Ty21a exposures. Transcript analysis of candidate innate immune gene (clec-60, clec-87, lys-7, ilys-3, scl-2, cpr-2, F08G5.6, atf-7, age-1, bec-1 and daf-16) regulations in the host during S. Typhi infection have been assessed through qPCR analysis to understand the activation of immune signaling pathways during S. Typhi infections. Gene silencing approaches confirmed that clec-60 and clec-87 has a major role in the defense system of C. elegans during S. Typhi infection. In conclusion, the study revealed that preconditioning of host with Ty21a protects against subsequent S. Typhi infection.

Entities:  

Keywords:  Caenorhabditis elegans; Innate immune response; Pre-exposed host; RNAi; Salmonella enterica serovar Typhi

Year:  2013        PMID: 24426167      PMCID: PMC3889844          DOI: 10.1007/s12088-013-0424-x

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  23 in total

Review 1.  Salmonella: from pathogenesis to therapeutics.

Authors:  Erin C Boyle; Jennifer L Bishop; Guntram A Grassl; B Brett Finlay
Journal:  J Bacteriol       Date:  2006-12-22       Impact factor: 3.490

Review 2.  Signaling in the immune response.

Authors:  Jonathan J Ewbank
Journal:  WormBook       Date:  2006-01-23

3.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

4.  A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans.

Authors:  D M Hone; S R Attridge; B Forrest; R Morona; D Daniels; J T LaBrooy; R C Bartholomeusz; D J Shearman; J Hackett
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

5.  Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection.

Authors:  Stephen J Libby; Michael A Brehm; Dale L Greiner; Leonard D Shultz; Michael McClelland; Kelly D Smith; Brad T Cookson; Joyce E Karlinsey; Traci L Kinkel; Steffen Porwollik; Rocio Canals; Lisa A Cummings; Ferric C Fang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

6.  Inducible antibacterial defense system in C. elegans.

Authors:  Gustavo V Mallo; C Léopold Kurz; Carole Couillault; Nathalie Pujol; Samuel Granjeaud; Yuji Kohara; Jonathan J Ewbank
Journal:  Curr Biol       Date:  2002-07-23       Impact factor: 10.834

7.  Genetic stability of vaccine strain Salmonella Typhi Ty21a over 25 years.

Authors:  Dennis J Kopecko; Heike Sieber; Jose A Ures; Andreas Fürer; Jacqueline Schlup; Ulrich Knof; Andre Collioud; Deqi Xu; Kevin Colburn; Guido Dietrich
Journal:  Int J Med Microbiol       Date:  2009-01-01       Impact factor: 3.473

8.  The genetics of Caenorhabditis elegans.

Authors:  S Brenner
Journal:  Genetics       Date:  1974-05       Impact factor: 4.562

9.  p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans.

Authors:  Emily R Troemel; Stephanie W Chu; Valerie Reinke; Siu Sylvia Lee; Frederick M Ausubel; Dennis H Kim
Journal:  PLoS Genet       Date:  2006-09-11       Impact factor: 5.917

10.  Genome-wide investigation reveals pathogen-specific and shared signatures in the response of Caenorhabditis elegans to infection.

Authors:  Daniel Wong; Daphne Bazopoulou; Nathalie Pujol; Nektarios Tavernarakis; Jonathan J Ewbank
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  5 in total

1.  Intrinsic JNK-MAPK pathway involvement requires daf-16-mediated immune response during Shigella flexneri infection in C. elegans.

Authors:  Shanmugam Marudhupandiyan; Krishnaswamy Balamurugan
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

2.  Proteomic analysis of Caenorhabditis elegans against Salmonella Typhi toxic proteins.

Authors:  Dilawar Ahmad Mir; Boopathi Balasubramaniam; Lappasi Mohanram VenkataKrishna; Balasubramanian Chellammal Muthubharathi; Krishnaswamy Balamurugan
Journal:  Genes Immun       Date:  2021-05-14       Impact factor: 2.676

3.  The Invertebrate Lysozyme Effector ILYS-3 Is Systemically Activated in Response to Danger Signals and Confers Antimicrobial Protection in C. elegans.

Authors:  Maria João Gravato-Nobre; Filipa Vaz; Sergio Filipe; Ronald Chalmers; Jonathan Hodgkin
Journal:  PLoS Pathog       Date:  2016-08-15       Impact factor: 6.823

4.  Hsp90-downregulation influences the heat-shock response, innate immune response and onset of oocyte development in nematodes.

Authors:  Julia Eckl; Siyuan Sima; Katrin Marcus; Claudia Lindemann; Klaus Richter
Journal:  PLoS One       Date:  2017-10-27       Impact factor: 3.240

5.  Planococcus maritimus ML1206 Isolated from Wild Oysters Enhances the Survival of Caenorhabditis elegans against Vibrio anguillarum.

Authors:  Ying-Xiu Li; Nan-Nan Wang; Yan-Xia Zhou; Chun-Guo Lin; Jing-Shan Wu; Xin-Qi Chen; Guan-Jun Chen; Zong-Jun Du
Journal:  Mar Drugs       Date:  2021-03-12       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.